The DOI matches its Crossref record.
SENILE MACULAR DEGENERATION: A CASE-CONTROL STUDY
Abstract
Senile macular degeneration, although a leading cause of visual loss in the United States, remains a poorly understood disease. To assess the effects of host and environmental factors on this condition, a study of 228 cases and 237 controls matched by age and sex, who had visited any of 34 Baltimore ophthalmologists between September 1, 1978 and March 31, 1980, was conducted. Study participants were interviewed for past medical, residential, occupational, smoking and family histories, as well as social and demographic factors. Diagnoses were validated by means of fundus photographs. The 162 cases and 175 controls who met the study diagnostic criteria for cases and controls were included in the analysis. Statistically significant associations were demonstrated between senile macular degeneration and family history of macular disease (odds ratio (OR) = 2.9), chemical work exposures (OR = 4.2), blue or medium pigmented eyes (OR = 3.5), history of one or more cardiovascular diseases (OR = 1.7), decreased hand grip strength, and hyperopia. The risk of macular degeneration in cigarette smokers was significant for males only (OR = 2.6). The study results suggest that the development of macular degeneration is mainly influenced by familial, genetic, and personal characteristics, rather than by the few environmental factors studied. Additional studies are needed to further evaluate the role of environmental factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results from a number of case-control studies,28–33 population-based studies,34–36 and prospective studies of both physicians37 and nurses38 strongly confirm cigarette smoking as a risk factor for age-related macular degeneration.”
From Age-related macular degeneration (2008) · cites this paper as [30]
In the citing paper
“Blue iris colour has been inconsistently implicated as a risk factor for age-related macular degeneration and has been considered a possible marker for pigment content in the retinal pigment epithelium.109,110”
From Age-related macular degeneration (2008) · cites this paper as [109]
Citations
Cited by
Sorted by citations
Items 501–588 of 588
Thermal Laser Treatment in AMD: Therapeutic and Prophylactic
Cukras, C. A., & Fine, S. L. (2006) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31802bda65 · Cited by 2
Self-citationCase-Control Design: Making the Case
FLETCHER, A. E. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.08.019 · Cited by 2
Age-related macular degeneration : a light and electron microscopical study
van der Schaft, T. L. (1993) · Cited by 2
Hematological Disorders and the Retina
Reynolds, S. A., & Rodman, J. (2008) · Cited by 2
Epidemiology of Age-Related Macular Degeneration
Hyman, L. (1987) · Cell and developmental biology of the eye · doi:10.1007/978-1-4612-4784-5_11 · Cited by 2
Self-citationROLE OF DIETARY SUPPLEMENTATION IN PREVENTING PROGRESSION OF AGE-RELATED MACULAR DEGENERATION
Ermakova, N. A. (2016) · Ophthalmology in Russia · doi:10.18008/1816-5095-2016-3-163-168 · Cited by 2
Sinclair, A. J., & Croxson, S. C. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6231-8.10092-3 · Cited by 2
Genetik der altersabhängigen Makuladegeneration
Stöhr, H., & Weber, B. H. F. (2004) · Springer eBooks · doi:10.1007/978-3-662-05681-3_2 · Cited by 2
Gene therapy in age-related macular degeneration
Maurya, R. P., & Gupta, S. V. (2023) · Indian Journal of Clinical and Experimental Ophthalmology · doi:10.18231/j.ijceo.2023.001 · Cited by 2
Haplotypes of RHO polymorphisms and susceptibility to age-related macular degeneration.
Tang, K., Wang, W., Wang, Q., Wang, L., Bai, H., Jiang, Y., & Huang, Y. (2015) · PubMed Central · Cited by 2
Lifestyle and age-related macular degeneration
Wickremasinghe, S., Chong, E. W. T., & Guymer, R. H. (2009) · Expert Review of Ophthalmology · doi:10.1586/17469899.4.1.79 · Cited by 2
ROP in Soroka Medical Center Neonatal I.C.U
Monos, T., Yassur, Y., Lifshitz, T., et al. (1987) · Documenta ophthalmologica. Proceedings series · doi:10.1007/978-94-009-3337-8_30 · Cited by 2
DISCIFORM MACULAR DEGENERATION: A REVIEW OF THE DISEASE AND ITS MANAGEMENT
Chisholm, I. H. (1987) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1987.tb00077.x · Cited by 2
TREATMENT OF RETINAL DISEASE IN THE NEW MILLENNIUM
DEJUANJR, E., Cooney, M. J., Humayun, M. S., & Jensen, P. S. (1999) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(05)70132-2 · Cited by 2
Pawlak, D., Glacet-Bernard, A., Papp, M., COSCAS, G. J., & Soubrane, G. (2004) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(04)96270-5 · Cited by 2
“La forme exsudative, malgré une faible prévalence (8 à 20 % des DMLA selon les études), serait responsable de 80 % des cas de perte sévère d’acuité visuelle [2, 3].”
Macular degeneration in older adults
Moore, L. W. (2001) · Geriatric Nursing · doi:10.1067/mgn.2001.115206 · Cited by 2
Risk Profiles for Ageing Macular Disease
de Jong, P. T. V. M. (2004) · Ophthalmologica · doi:10.1159/000079462 · Cited by 2
(2000) · Time to knit · doi:10.1016/s0246-0343(19)30169-8 · Cited by 2
Molecular Genetic Studies of Retinal Dystrophies Principally Affecting the Macula
Gregory-Evans, K., Gregory, C. Y., Wijesuriya, S. D., Jay, M., Chopdar, A., & Bhattacharya, S. S. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1897-6_36 · Cited by 2
Investigations of a possible link between age-related macular degeneration and atherosclerosis.
Sivaprasad, S. (2005) · CERES (Cranfield University) · Cited by 2
Ghasemi, M., Ghasemi, A., Behjati, J., & Nikkhah, H. (2026) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-026-07119-1 · Cited by 1
Ophthalmology update for the primary practitioner
Sarrafizadeh, R., & Trese, M. T. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90014-2 · Cited by 1
Age-related macular disease : studies on incidence, risk factors, and prognosis
van Leeuwen, R. (2003) · Cited by 1
Epidemiology of Age-Related Macular Degeneration Early in the 21st Century
Wang, J. J., Mitchell, P., & Klein, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_2 · Cited by 1
Klein, R., & Klein, R. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_19 · Cited by 1
Epidemiology and Risk Factors in Age-Related Macular Degeneration (AMD)
Davoudi, S., & Sobrin, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_124 · Cited by 1
Likhvantseva, V. G., Gevorgyan, A. S., Kapkova, S. G., Рычкова, С. И., & Borisenko, T. E. (2024) · Ophthalmology in Russia · doi:10.18008/1816-5095-2024-1-117-127 · Cited by 1
Influence of vitrectomyon the progressionof wet age related macular degeneration
Astakhov, Y. S., Shaar, G. B., & Dal, N. Y. (2014) · Ophthalmology Reports · doi:10.17816/ov2014413-21 · Cited by 1
Petrash, J. M., Ruzycki, P. A., & Zablocki, G. J. (2011) · Human Genomics · doi:10.1186/1479-7364-5-6-519 · Cited by 1
“Nischler and colleagues found that a specific CFH genotype (402H) correlated with lower visual acuity outcome after treatment with bevacizumab, suggesting that CFH plays a role in the response to the treatment of wet AMD.6 Additional GWAS results pointed to new risk variants in the region of chromosome 10 containing t…”
BackgroundInfluentialElhamamsy, M., Souka, A., Assi, H. E., Ashraf, M., & Kassem, H. S. (2017) · Middle East Journal of Medical Genetics · doi:10.1097/01.mxe.0000512347.39933.9c · Cited by 1
“Case–control association studies reported genetic predisposition to AMD (Hyman et al., 1983).”
BackgroundSingh, A. K., Untoo, R. A., Wani, O. A., & Rashid, W. (2022) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20220015 · Cited by 1
Klinische Manifestationsformen und Prognose
Holz, F. G., & Pauleikhoff, D. (2004) · Springer eBooks · doi:10.1007/978-3-662-05681-3_5 · Cited by 1
Subretinal new vessel recurrence in age‐related macular degeneration
Constable, I. J., Walker, L. N., & McAllister, I. L. (1989) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1989.tb00532.x · Cited by 1
GENETIC INFLUENCE ON EARLY AGE-RELATED MACULOPATHY
Sharma, S. (2002) · Evidence-Based Eye Care · doi:10.1097/00132578-200207000-00022 · Cited by 1
Legacy of the age-related eye disease [corrected] study.
Miller, J. W. (2009) · A M A Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.321
Genes and Age-Related Macular Degeneration
Guymer, R. H., Narendran, N., & Baird, P. N. (2005) · Springer eBooks · doi:10.1007/3-540-26977-0_4 · Cited by 1
Condição de saúde ocular em idosos residentes em asilos de Curitiba - Brasil
Avila, S. Z., Ramos, A. R. B., Moreira, H., et al. (1993) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.19930047 · Cited by 1
Reategui-Escalante, G., Murillo-Lopez, S. A., Romero, R. M., et al. (2003) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/1542-8877-20031101-03 · Cited by 1
Reading performance with stand magnifiers in age-related macular degeration
Cheong, A. M. Y. (2003) · Cited by 1
Shipp, M. D. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7506-7359-4.50021-7 · Cited by 1
Hosseinaee, Z., Abbasi, N., Khali, L., et al. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.09060 · Cited by 1
Klaver, C. C. W., van Leeuwen, R., Vingerling, J. R., & de Jong, P. T. V. M. (2004) · Springer eBooks · doi:10.1007/978-3-662-05681-3_1 · Cited by 1
The genetic associations of rhegmatogenous retinal detachment and ectopia lentis
Chandra, A. (2014) · UCL Discovery (University College London)
New Developments in cSLO Fundus Imaging
Staurenghi, G., Levi, G., Pedenovi, S., et al. (2007) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-33672-3_2
“Geographic atrophy of the RPE is a frequent cause of severe visual loss in patients with AMD, and it is responsible for approximately 20% of legal blindness [32].”
BackgroundPGE1 in Patients with Macular Degeneration
Heidrich, H., Harnisch, H., & Ranft, J. R. (1986) · Springer eBooks · doi:10.1007/978-3-642-71679-9_14
Maculopatía relacionada con la edad. Conceptos actuales, terapéutica y rehabilitación visual
Serrano, A. P., & Bringas, A. R. (2003) · Revista Mexicana de Oftalmología
Hiscox, R. (2013) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Calidad de imagen en sujetos afectados de degeneración macular asociada a la edad y queratitis
Herrera, C. O. (2011) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Age-related maculopathy: A genetic and epidemiological approach
Willemse-Assink, J. J. M. (2000) · EUR Research Repository (Erasmus University Rotterdam)
Subfoveal Choroidal Neovascular Membranes Secondary to Age-Related Macular Degeneration: A Review
Guyer, D. R., Murphy, R. P., & Fine, S. (1987) · Documenta ophthalmologica. Proceedings series · doi:10.1007/978-94-009-3337-8_32
Self-citationExacerbation of Age‐Related Macular Degeneration Following Cataract Extraction
Potter, J. W., & Austin, J. K. (1985) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.1985.tb00996.x
Kumar, K., Barguja, P., V., S. G. S. R. R., & Kubrey, S. S. (2013) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/1490
Repeat laser coagulation of subretinal neovascularization in age-related macular degeneration
Krott, R., Rößler, G., & Heimann, K. (1999) · Der Ophthalmologe · doi:10.1007/s003470050472
“Mangelernährung oder hohe UV-Belastung konnten bisher nicht eindeutig als Risikofaktoren identifiziert werden [8, 25].”
BackgroundManifestationsformen und Prognose
Holz, F. G., & Pauleikhoff, D. (1997) · Springer eBooks · doi:10.1007/978-3-662-11126-0_4
EPIDEMIOLOGY OF AGE-RELATED MACULOPATHY
Bosman, F. T. (2010)
Interferon alfa therapy for age-related macular degeneration
Reddy, U. U., & Kryzstolik, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005138
Managing patients at risk for age-related macular degeneration: a Canadian strategy
Somani, S., Hoskin-Mott, A., Mishra, A., Bois, A., Book, B. H., Chute, M., Gaucher, R., & Winter, B. (2019) · Canadian journal of optometry/CJO. Canadian journal of optometry · doi:10.15353/cjo.71.667
Plasma Biomarkers for Age-Related Macular Degeneration
Ni, J. (2009) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Génétique des dégénérescences maculaires.
Kaplan, J., Rozet, J., Gerber, S., Souied, E. H., Perrault, I., Ducroq, D., & Münnich, A. (1998) · médecine/sciences · doi:10.4267/10608/971
Age-related macular degeneration in Hong Kong Chinese — angiographic features and outcomes
Wu, P. K. W., Fu, R. C., & Chan, C. W. N. (2000) · Hong Kong Journal of Ophthalmology · doi:10.12809/hkjo-v4n1-135
Miller, D. R., & Scott, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-04332-8.00006-8
The Role of Lipids and Lipid Metabolism in Age-Related Macular Degeneration
Modjtahedi, B. S., Kishan, A. U., Mathew, S. S., & Morse, L. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401717-7.00007-1
Vessel formation and feeder vessel treatment in choroidal neovascularization
Wolfe, J. D. (2004) · OhioLink ETD Center (Ohio Library and Information Network)
Cellular uptake and actions of bilberry anthocyanins in retinal pigment epithelial cells
Milbury, & Everett, P. (2006) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
Macular pigment in monozygotic twins
Hammond, B. R. (1994) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
Ophthaproblem. Macular degeneration.
Sharma, S. (1997) · PubMed
Gestion des patients à risque de dégénérescence maculaire liée à l'âge : une stratégie canadienne
Somani, S., Hoskin-Mott, A., Mishra, A., Bois, A., Book, B. H., Chute, M., Gaucher, R., & Winter, B. (2009) · Canadian journal of optometry/CJO. Canadian journal of optometry · doi:10.15353/cjo.71.669
Youn, J.-H., Sohn, S., & Youn, J.-T. (2020) · The Korean Journal of Vision Science · doi:10.17337/jmbi.2020.22.2.147
Epidemiology and Risk Factors in Age-Related Macular Degeneration (AMD)
Davoudi, S., & Sobrin, L. (2020) · Springer eBooks · doi:10.1007/978-3-319-90495-5_124-1
Comparative Analysis Of The Results Of Anti-VEGF Therapy In Patients With AMD
Vidinova, H., Antonova, D., & Voynov, L. (2021) · Bulgarian Review of Ophthalmology · doi:10.14748/bro.v65i2.7825
“През 2011-2013 г. се появи сравнително нов медикамент ‒ aflibercept (Eylea), който представлява човешки протеин с по-голям афинитет на свързване към VEGF-A от досега съществуващите, но който също се свързва с VEGF-B и плацентарния растежен фактор [7, 10].”
Hosseinaee, Z., Abbasi, N., Khalili, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-289633/v1
Vingerling, H. (2006) · Bijblijven · doi:10.1007/bf03059929
Is smoking a risk factor for AMD
Armstrong, R. A. (2003) · Aston Publications Explorer (Aston University)
Risk Factors for Age-related Macular Degeneration in Benin City, Southern Nigeria
Otabor-Olubor, O. J., Ekechukwu, L. O., Uhumwangho, O. M., & Omoti, A. E. (2021) · Nigerian Journal of Ophthalmology · doi:10.4103/njo.njo_7_20
Age-Related Macular Degeneration
(2007) · Humana Press eBooks · doi:10.1007/978-1-59259-979-0_3
Scanning Laser Ophthalmoscope in the Management of Age-related Macular Degeneration
Scripsema, N. K., & Rosen, A. R. B. (2012) · European Ophthalmic Review · doi:10.17925/eor.2012.06.04.242
Degeneração macular relacionada à idade
Rim, P. H. H. (2012) · doi:10.47749/t/unicamp.2012.853614 · Cited by 1
The Role of Lipids and Lipid Metabolism in Age-Related Macular Degeneration
Fortenbach, C. R., Goldman, E., Kishan, A. U., Mathew, S. S., Modjtahedi, B. S., & Morse, L. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815245-4.00004-1
Klaver, C. C. W., Vingerling, J. R., Hofman, A., & de Jong, P. T. V. M. (1997) · Springer eBooks · doi:10.1007/978-3-662-11126-0_1
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy (IPCV)
Yannuzzi, L. A., Ciardella, A. P., Spaide, R. F., et al. (1998) · Documenta ophthalmologica. Proceedings series · doi:10.1007/978-94-011-5137-5_27
(2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3320-9.50015-5
Study of Risk Factors Associated with Age Related Macular Degeneration in North Indian Population
Gupta, S., Mittal, D. S., Mittal, D. C., & Gupta, A. (2022) · Scholars Journal of Applied Medical Sciences · doi:10.36347/sjams.2022.v10i09.001
(2000) · Time to knit · doi:10.1016/s0246-0343(13)60154-9
Hirai, C., Shiraishi, E., Tsuchida, H., et al. (2025) · Cureus · doi:10.7759/cureus.77606
Iris color distribution in the United States of America
Hashem, F., Menicacci, C., & Granet, D. B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0312913
“Also, other reports found that AMD is related to lighter iris colors [16–18].”
Sparrow, J. R. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_5
Baseline visual acuity gaps in age-related macular degeneration: AREDS smokers and non-smokers
Pan, M., Sunkara, N., Digbeu, B. D. E., & Gupta, P. K. (2026) · BMC Ophthalmology · doi:10.1186/s12886-026-05035-w
“…risk factor for AMD among several that have been identified, including older age, hypertension, cardiovascular disease, and family history [7, 8], with current smokers carrying a greater than 6-fold increased risk of neovascular AMD compared to non-smokers and former smokers retaining more…”
Berrow, E. J. (2012) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00016328
Metadata
- Authors
- HYMAN, L. G., LILIENFELD, A. M., FERRIS, F. L., & FINE, S. L.
- Affiliations
- State University of New York (US)
- Johns Hopkins University (US)
- National Institutes of Health (US)
- Corresponding author
- HYMAN, LESLIE G.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-08
- Volume
- 118
- Issue
- 2
- Pages
- 213-227
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2147440920
- Cited by
- 587
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 13 · 2013: 16 · 2012: 18
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- senile macular degeneration, risk factors, family history (medicine), genetic susceptibility, chemical exposure, occupational exposure, eye pigmentation, cardiovascular disease, grip strength, hyperopia, smoking, vision loss
- MeSH terms
- Aged, Cardiovascular Diseases, Environmental Exposure, Eye Color, Female, Humans, Macular Degeneration, Male, Maryland, Refractive Errors, Risk, Sex Factors, Smoking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review